| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, Sept. 26 /PRNewswire/ -- John Cousins, President and Chief Executive Officer of Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com) will be featured in an exclusive interview with http://www.wallst.net scheduled for September 28 at 1 p.m. EDT. The interview will be posted on http://www.wallst.net by 8 p.m. EDT on September 28.
The interview will cover topics including Biomoda's market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.
To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section.
About Biomoda:
Biomoda is committed to the vision that the early detection of cancer is achievable in our lifetime. Through the developments of our technologies and an array of complimentary business models, Biomoda is creating diagnostic tools to assist clinicians in early detection, staged diagnosis and aid in determining therapy routes. Biomoda's prototype tests are inexpensive, simple and accurate. Our business plan is to focus on economically large markets where our proprietary, patented technology will significantly reduce overall costs in the healthcare system and improve patient outcomes. At Biomoda, our mission is to create and market new diagnostic solutions for the early detection and clinical management of cancer; solutions that provide compelling value to the healthcare system through cost savings and improved patient outcomes.
For more informatio
'/>"/>
| SOURCE Financial Filings Corp. Copyright©2007 PR Newswire. All rights reserved |